John Overdeck’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,034
Closed -$477K 4389
2025
Q3
$477K Buy
22,034
+4,137
+23% +$92.3K ﹤0.01% 3009
2025
Q2
$398K Sell
17,897
-9,800
-35% -$218K ﹤0.01% 2678
2025
Q1
$658K Sell
27,697
-15,641
-36% -$370K ﹤0.01% 2389
2024
Q4
$917K Buy
43,338
+20,949
+94% +$550K ﹤0.01% 2231
2024
Q3
$722K Buy
22,389
+1,290
+6% +$38.1K ﹤0.01% 2290
2024
Q2
$502K Sell
21,099
-17,969
-46% -$461K ﹤0.01% 2367
2024
Q1
$1.17M Sell
39,068
-32,332
-45% -$1.01M ﹤0.01% 1857
2023
Q4
$2.28M Buy
71,400
+28,400
+66% +$824K 0.01% 1426
2023
Q3
$1.26M Sell
43,000
-3,300
-7% -$119K ﹤0.01% 1804
2023
Q2
$2.08M Buy
46,300
+3,300
+8% +$126K 0.01% 1412
2023
Q1
$1.48M Sell
43,000
-126,987
-75% -$4.12M ﹤0.01% 1621
2022
Q4
$4.74M Buy
169,987
+113,437
+201% +$3M 0.01% 885
2022
Q3
$1.32M Buy
+56,550
New +$1.81M ﹤0.01% 1345
2021
Q4
Sell
-73,714
Closed -$3.12M 4825
2021
Q3
$3.12M Buy
+73,714
New +$3.76M 0.01% 1581
2020
Q2
Sell
-68,722
Closed -$449K 3463
2020
Q1
$449K Buy
+68,722
New +$980K ﹤0.01% 2016
2016
Q1
Sell
-11,529
Closed -$236K 3091
2015
Q4
$236K Buy
+11,529
New +$220K ﹤0.01% 2376

Other funds holding SGRY

John Overdeck's SGRY Position: Q4 2025 in Review

John Overdeck sold out of Surgery Partners (SGRY) in Q4 2025, closing a stake of 22,034 shares — an estimated $477K sold.

John Overdeck first reported a position in SGRY in Q4 2015 and held it in 16 quarters. The position peaked at $4.74M in Q4 2022. 180 funds tracked by Wall St. Rank hold SGRY as of Q4 2025.

  • John Overdeck reported no remaining Surgery Partners position as of Q4 2025 after selling out during the quarter.
  • John Overdeck sold 22,034 Surgery Partners shares in Q4 2025, an estimated $477K.
  • John Overdeck first reported a position in Surgery Partners in Q4 2015 and held it in 16 quarters.
  • John Overdeck's Surgery Partners position peaked at $4.74M in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.